Join us for an industry session and learn more about the Future of Precision Medicine: Advancements in Nanoscale Genomics
Explore the latest breakthroughs in pharmacogenomics and personalized medicine in this industry session. Don’t miss the opportunity to hear from leading experts in the field as they discuss transformative advancements in genomics technology and its implications for mental health treatment.
Industry Education Sessions l Room 108
Thursday, November 7 | 3:00 – 4:00 pm
Dr. Katherine Aitchison
Associate Director of Mental Health, Neuroscience and Mental Health Institute, University of Alberta
Dr. Aitchison will explore how advancements in psychiatric pharmacogenomics are revolutionizing mental health care. Discover the impact of genetic variations on medication responses and how these insights are leading to personalized treatments that promise improved patient outcomes.
Dr. Naveen Ramalingam
Senior Director of Microfluidics and Genomics Development, Standard BioTools
Dr. Ramalingam will present revolutionary applications of nanofluidic qPCR technology. Learn how this cutting-edge approach enhances variant detection, simplifies workflows, and accelerates the movement toward precision medicine—offering comprehensive coverage of AMP Tier 1 genomic targets.
Yes, I'd like to join this session.
For Research Use Only. Not for use in diagnostic procedures. Patent and License Information: www.standardbio.com/legal/notices. Trademarks: www.standardbio.com/legal/trademarks. Any other trademarks are the sole property of their respective owners. ©2024 Standard BioTools Inc. All rights reserved.